550. Is it Time to Re-Think the Post-Immigration Tuberculosis Surveillance System in Canada?
Session: Poster Abstract Session: Tuberculosis Epidemiology and Diagnosis
Thursday, October 27, 2016
Room: Poster Hall
Background: The post-arrival tuberculosis (TB) surveillance system in Canada is inefficient. Ideally, it identifies new permanent residents at increased risk of post-arrival TB. However, the current system has low coverage, poor post-arrival compliance, and low rates of active TB diagnosis in the immediate post-arrival period. The focus is not on latent TB infection (LTBI) diagnosis and/or treatment. The objective of this study was to simulate the effect of improving the current two-year post-immigration surveillance system on TB incidence.

Methods: The 2014 Canadian permanent resident cohort was used as the reference population for this evaluation. A discrete event simulation model was developed in Simio, simulating pre-entry surveillance flagging, post-immigration follow-up, LTBI diagnosis and treatment, and incident TB over a two-year time horizon. Post-immigration TB incidence data from Ontario and California were used to populate the model. The model was validated against two-year TB incidence in Ontario. Increased LTBI treatment uptake and surveillance compliance and their impact on two-year TB incidence were modeled.

Results: The current surveillance system flags 2.4% of new permanent residents for surveillance, with 59.8% complying post-arrival, and 15-68% completing LTBI treatment. TB incidence in the first two years under the current system was predicted to be 27.3 per 100,000 person years (PY). Removing the surveillance program entirely would result in 27.7 cases per 100,000 PY, corresponding to only a 1.5% increase. A perfect program with full surveillance compliance and LTBI treatment completion would result in 26.2 cases per 100,000 PY, corresponding to a 4.4% decrease.

Conclusion: The current post-landing surveillance program does little to prevent active TB diagnoses in Canada. Canada could consider shifting to pre-immigration LTBI screening and treatment, reconsider criteria for surveillance to target LTBI post-landing, or help support TB control efforts in high TB incidence countries.

Jonathon Campbell, BSc1, James Johnston, MD2,3, Victoria Cook, M.D.2,3, Mohsen Sadatsafavi, M.D., Ph.D.1 and Fawziah Marra, BSc (Pharm), Pharm.D.1, (1)Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, (2)British Columbia Centre for Disease Control, Vancouver, BC, Canada, (3)Respirology, University of British Columbia, Vancouver, BC, Canada

Disclosures:

J. Campbell, None

J. Johnston, None

V. Cook, None

M. Sadatsafavi, None

F. Marra, None

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.